Insider holders · CIK 0001175505
FIVE PRIME THERAPEUTICS INC · FPRX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Phillip Gross10% Owner | — | 2,539,949 | 2,539,949 | Oct 19, 2015 · 4:19 pm EDT | Form 4 |
| Robert Atchinson10% Owner | — | 2,539,949 | 2,539,949 | Oct 19, 2015 · 4:19 pm EDT | Form 4 |
| Adage Capital Advisors, L.L.C.10% Owner | — | 2,539,949 | 2,539,949 | Oct 19, 2015 · 4:19 pm EDT | Form 4 |
| ADAGE CAPITAL PARTNERS GP LLC10% Owner | — | 2,539,949 | 2,539,949 | Oct 19, 2015 · 4:19 pm EDT | Form 4 |
| Adage Capital Partners, L.P.10% Owner | — | 2,539,949 | 2,539,949 | Oct 19, 2015 · 4:19 pm EDT | Form 4 |
| Lewis T WilliamsDirector | 462,360 | — | 462,360 | Feb 28, 2019 · 6:15 pm EST | Form 4/A |
| Aron Marc KnickerbockerPresident & CEO | 218,445 | 14,238 | 232,683 | Feb 27, 2019 · 8:07 pm EST | Form 4 |
| Robert Steven SikorskiSVP and Chief Medical Officer | 104,158 | — | 104,158 | Mar 3, 2017 · 1:36 pm EST | Form 4 |
| Franklin M BergerDirector | 84,980 | — | 84,980 | Apr 26, 2016 · 7:26 pm EDT | Form 4 |
| Julie HambletonEVP & Chief Medical Officer | 84,811 | 64 | 84,875 | Nov 13, 2015 · 5:04 pm EST | Form 4 |
| Francis Willard SarenaChief Strategy Officer | 82,955 | — | 82,955 | Feb 27, 2019 · 7:53 pm EST | Form 4 |
| Kevin Paul BakerSVP, Development Sciences | 78,184 | — | 78,184 | Feb 28, 2018 · 7:23 pm EST | Form 4 |
| Luis BorgesSVP, Research | 64,888 | — | 64,888 | Mar 3, 2017 · 1:29 pm EST | Form 4 |
| Marc BelskySenior Vice President and CFO | 16,314 | 44,158 | 60,472 | Feb 28, 2018 · 7:24 pm EST | Form 4 |
| David V SmithExecutive Vice President & CFO | 40,000 | — | 40,000 | Nov 27, 2018 · 7:21 pm EST | Form 4 |
| Helen Louise CollinsSVP and Chief Medical Officer | 39,794 | — | 39,794 | Feb 27, 2019 · 7:58 pm EST | Form 4 |
| Bryan IrvingEVP, Chief Scientific Officer | 31,153 | — | 31,153 | Feb 27, 2019 · 8:01 pm EST | Form 4 |
| Fred E CohenDirector | 24,807 | — | 24,807 | Jan 13, 2016 · 5:05 pm EST | Form 4 |
| Brian Russell WongSVP, Research | 22,738 | — | 22,738 | Jun 24, 2015 · 5:11 pm EDT | Form 3 |
| R Lee DouglasDirector | 1,220 | 15,642 | 16,862 | Oct 13, 2016 · 1:02 pm EDT | Form 4 |
| David WhiteSee Remarks | 15,000 | — | 15,000 | Mar 4, 2019 · 6:21 pm EST | Form 4 |
| Mark McDadeDirector | 12,601 | — | 12,601 | Oct 4, 2016 · 7:45 pm EDT | Form 4 |
| William R RingoDirector | 10,000 | — | 10,000 | Jan 11, 2019 · 6:07 pm EST | Form 4 |
| Peder JensenDirector | 0 | — | 0 | Nov 10, 2016 · 1:53 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.